588 related articles for article (PubMed ID: 15745374)
21. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis.
Walter Canonica G; Bousquet J; Van Hammée G; Bachert C; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB;
Respir Med; 2006 Oct; 100(10):1706-15. PubMed ID: 16723217
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine.
Patou J; De Smedt H; van Cauwenberge P; Bachert C
Clin Exp Allergy; 2006 Aug; 36(8):972-81. PubMed ID: 16911353
[TBL] [Abstract][Full Text] [Related]
23. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
[TBL] [Abstract][Full Text] [Related]
24. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters.
Pasquali M; Baiardini I; Rogkakou A; Riccio AM; Gamalero C; Descalzi D; Folli C; Passalacqua G; Canonica GW
Clin Exp Allergy; 2006 Sep; 36(9):1161-7. PubMed ID: 16961716
[TBL] [Abstract][Full Text] [Related]
25. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of levocetirizine in seasonal allergic rhinitis.
Leynadier F; Mees K; Arendt C; Pinelli ME
Acta Otorhinolaryngol Belg; 2001; 55(4):305-12. PubMed ID: 11859651
[TBL] [Abstract][Full Text] [Related]
27. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
Maiti R; Rahman J; Jaida J; Allala U; Palani A
Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
[TBL] [Abstract][Full Text] [Related]
28. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
[TBL] [Abstract][Full Text] [Related]
29. Association between response to decongestion testing and sensitizations and allergic inflammation.
Ciprandi G; Cirillo I; Klersy C; Vizzaccaro A; Tosca MA; Marseglia GL
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):431-6. PubMed ID: 16597077
[TBL] [Abstract][Full Text] [Related]
30. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity.
Ciprandi G; Cirillo I; Vizzaccaro A; Monardo M; Tosca MA
Respir Med; 2005 Dec; 99(12):1606-12. PubMed ID: 16291083
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial.
Tzanetos DB; Fahrenholz JM; Scott T; Buchholz K
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):517-22. PubMed ID: 22123381
[TBL] [Abstract][Full Text] [Related]
32. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites.
Potter PC;
Allergy; 2003 Sep; 58(9):893-9. PubMed ID: 12911418
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
34. Relationship between rhinitis duration and response to nasal decongestion test.
Ciprandi G; Pistorio A; Tosca M; Cirillo I
Laryngoscope; 2008 Jul; 118(7):1139-41. PubMed ID: 18425049
[TBL] [Abstract][Full Text] [Related]
35. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
36. Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization.
Ciprandi G; Marseglia GL; Klersy C; Tosca MA
Allergy; 2005 Jul; 60(7):957-60. PubMed ID: 15932388
[TBL] [Abstract][Full Text] [Related]
37. Levocabastine nasal spray significantly improves perennial allergic rhinitis: a single-blind placebo-controlled study.
Okubo K; Uchida E; Nogami S
Auris Nasus Larynx; 2010 Aug; 37(4):436-42. PubMed ID: 20138720
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
39. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
[TBL] [Abstract][Full Text] [Related]
40. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
Stübner P; Zieglmayer R; Horak F
Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
